Valeo Financial Advisors, LLC: OEF position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Valeo Financial Advisors, LLC on OEF, newest first. How the timeline and the estimate are built.
Valeo Financial Advisors, LLC held 1,124 OEF shares at 2026-09-30 per its 13F-HR filed 2026-10-08.
the latest 13F is the newest step
- period ended2026-09-3013F 1,124 sharesChange vs previous 13F -1 shares
0.01% of the 13F portfolio, value $429,458.
13F-HR 0001722641-26-000006 filed by Valeo Financial Advisors, LLC
Accepted , ingested - period ended2026-06-3013F 1,125 sharesChange vs previous 13F +48 shares
0.01% of the 13F portfolio, value $411,604.
13F-HR 0001722641-26-000004 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,077 sharesChange vs previous 13F -298 shares
0.01% of the 13F portfolio, value $342,561.
13F-HR 0001722641-26-000003 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,375 sharesChange vs previous 13F +647 shares
0.01% of the 13F portfolio, value $471,584.
13F-HR 0001722641-26-000001 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 728 sharesChange vs previous 13F +16 shares
0.01% of the 13F portfolio, value $242,308.
13F-HR 0001722641-25-000007 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F/A 712 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $216,697.
13F-HR/A 0001722641-25-000005 filed by Valeo Financial Advisors, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).